Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.71B |
| 2 |
Microsoft
MSFT
|
+$3.52B |
| 3 |
Amazon
AMZN
|
+$2.04B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.87B |
| 5 |
Eli Lilly
LLY
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.8B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.78B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$703M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$611M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.3% |
| 2 | Healthcare | 12.11% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDS
3101
Precision Drilling
PDS
$979M
| $9.8M | ﹤0.01% |
127,821
-13,655
| -10% | -$985K |
|
3102
Viridian Therapeutics
VRDN
$2.3B
| $9.79M | ﹤0.01% |
335,302
+170,544
| +104% | +$3.93M |
|
3103
John Hancock Multifactor Developed International ETF
JHMD
$979M
| $9.79M | ﹤0.01% |
347,667
-183,711
| -35% | -$4.95M |
|
3104
Direxion NASDAQ-100 Equal Weighted Index ETF
QQQE
$1.38B
| $9.77M | ﹤0.01% |
153,080
+92,619
| +153% | +$5.96M |
|
3105
American Century Diversified Corporate Bond ETF
KORP
$888M
| $9.77M | ﹤0.01% |
215,494
+208,887
| +3,162% | +$9.42M |
|
3106
Sturm, Ruger & Co
RGR
$625M
| $9.76M | ﹤0.01% |
192,884
-24,714
| -11% | -$1.34M |
|
3107
Stewart Information Services
STC
$2.09B
| $9.75M | ﹤0.01% |
228,251
+99
| +0% | +$4.14K |
|
3108
Seaboard Corp
SEB
$4.21B
| $9.72M | ﹤0.01% |
2,574
+351
| +16% | +$1.32M |
|
3109
Matthews International
MATW
$880M
| $9.71M | ﹤0.01% |
318,948
+11,558
| +4% | +$323K |
|
3110
Global X FinTech ETF
FINX
$175M
| $9.7M | ﹤0.01% |
503,782
-230,966
| -31% | -$4.65M |
|
3111
Sterling Infrastructure
STRL
$16.6B
| $9.68M | ﹤0.01% |
295,261
+146,578
| +99% | +$4.31M |
|
3112
Fidelity MSCI Energy Index ETF
FENY
$1.97B
| $9.68M | ﹤0.01% |
406,130
-12,990
| -3% | -$310K |
|
3113
AtriCure
ATRC
$1.98B
| $9.68M | ﹤0.01% |
218,088
+71,570
| +49% | +$2.99M |
|
|
BWIN
3114
Baldwin Insurance Group
BWIN
$2.79B
| $9.67M | ﹤0.01% |
384,823
-3,961
| -1% | -$109K |
|
3115
Global Net Lease
GNL
$1.81B
| $9.67M | ﹤0.01% |
769,350
-110,884
| -13% | -$1.38M |
|
|
MFM
3116
Aberdeen Municipal Income Fund
MFM
$222M
| $9.65M | ﹤0.01% |
1,863,385
+464,829
| +33% | +$2.31M |
|
3117
Primoris Services
PRIM
$4.93B
| $9.63M | ﹤0.01% |
438,880
+30,109
| +7% | +$609K |
|
3118
Employers Holdings
EIG
$911M
| $9.62M | ﹤0.01% |
223,126
+48,322
| +28% | +$1.99M |
|
3119
Central Pacific Financial
CPF
$1.03B
| $9.62M | ﹤0.01% |
474,401
+32,191
| +7% | +$661K |
|
3120
EVI Industries
EVI
$182M
| $9.62M | ﹤0.01% |
403,038
+22,722
| +6% | +$446K |
|
|
SWTX
3121
DELISTED
SpringWorks Therapeutics
SWTX
| $9.62M | ﹤0.01% |
369,686
-385,931
| -51% | -$9.51M |
|
3122
Avantis US Equity ETF
AVUS
$14.4B
| $9.59M | ﹤0.01% |
141,010
+98,984
| +236% | +$6.76M |
|
3123
Hanmi Financial
HAFC
$960M
| $9.58M | ﹤0.01% |
387,208
-16,187
| -4% | -$412K |
|
|
GGN
3124
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$773M
| $9.57M | ﹤0.01% |
2,635,415
+799,989
| +44% | +$2.79M |
|
|
ICPT
3125
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $9.55M | ﹤0.01% |
772,380
-125,593
| -14% | -$1.78M |
|
Similar funds
Morgan Stanley's Q4 2022 Portfolio in Review
As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 200 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.
- Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
- Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
- Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
- Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
- Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
- Morgan Stanley opened 200 new positions and closed 311 in Q4 2022.
- Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.
Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.